Mediti Pharma Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Mediti Pharma General Information
Description
Developer of drugs designed to treat Alzheimer's disease. The company's drugs provide assistance to identify and cure early symptoms of the disease such as hallucinations, delusions and aggression, enabling healthcare providers to improve the lives of Alzheimer's disease patients.
Contact Information
Corporate Office
- 1255 Boule, Robert-Bourassa
- Suite 1610
- Montreal, Quebec H3B 3X3
- Canada
Corporate Office
- 1255 Boule, Robert-Bourassa
- Suite 1610
- Montreal, Quebec H3B 3X3
- Canada
Mediti Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 15-Apr-2021 | Completed | Out of Business | |||
| 1. Early Stage VC | 20-Jun-2016 | Completed | Startup |
Mediti Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Mediti Pharma FAQs
-
When was Mediti Pharma founded?
Mediti Pharma was founded in 2016.
-
Where is Mediti Pharma headquartered?
Mediti Pharma is headquartered in Montreal, Canada.
-
What industry is Mediti Pharma in?
Mediti Pharma’s primary industry is Drug Discovery.
-
Is Mediti Pharma a private or public company?
Mediti Pharma is a Private company.
-
What is Mediti Pharma’s current revenue?
The current revenue for Mediti Pharma is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
